An expert panel came together at Cencora’s ThinkLive Gene Therapy Summit 2024 during a session titled, “Leveraging past learnings for future-focused solutions to clinical manufacturing.” Led by moderator Christian K. Schneider, M.D., Vice President and Head of BioPharma Excellence, Cencora PharmaLex, leaders from industry and former regulators discussed their experiences with Chemistry, Manufacturing, and Controls (CMC) and clinical manufacturing during early and late-stage development of cell and gene therapies.